IPO Boutique Research, Color & More Information for Subscribers
Thursday Expected Pricings Inovalon Holdings (Nasdaq: INOV) – Inovalon Holdings prices IPO $1.00 above the already upwardly-revised range. ‘INOV’ prices 22.2 million shares at $27.00 and will debut on Thursday (2/12). Invitae Corporation (NYSE: NVTA) – Invitae Corp. upsized and priced its IPO above the range. ‘NVTA priced 6.35 million shares at $16.00 and will[…]
Wednesday Autogenomics (Nasdaq: AGMX) – We have been informed by the underwriter that the deal will likely not price tonight. We will have more information when it becomes available. Sol-Wind Renewable Power (NYSE: SLWD) – The underwriter says that this deal will now price on Wednesday (2/11) in hopes of a Thursday (2/12) debut. Rest[…]
Coupons.Com went public on March 7 to very strong public demand. $COUP priced 10.5 million shares at $16.00 and opened 70% higher with a first trade of $27.15. The stock’s intra-day, $33.00, high happened on day one.By early August, the deal was trading below its offering price and on Monday the company reported dismal earnings[…]
This past week three IPOs debuted, five updated terms and three new deals filed. It was a tough week for many deals planning to come to market as just three of the eleven IPOs on the schedule priced and debuted.
Tuesday Avenue Financial Holding (Nasdaq: AVNU) Wednesday Autogenomic (Nasdaq: AGMX) Sol-Wind Renewable Power (NYSE: SLWD) Thursday Inovalon Holdings (Nasdaq: INOV) Invitae Corporation (NYSE: NVTA) Friday Bellerpheron Therapeutics (Nasdaq: BLPH) Great AJax Corp (NYSE: AJX) Day-to-Day Infraredx (Nasdaq: REDX) Inotek Pharmaceuticals Corporation (Nasdaq: ITEK) Eyegate Pharmaceuticals (Nasdaq: EYEG)
The week started with 11 deals “scheduled” to come to market with only three pricing and coming to market. We won’t focus on the eight deals that failed to price…but we will look at one of the deals that is making its debut today, Columbia Pipeline Partners (NYSE: CPPL). Columbia Pipeline Partners, the midstream affiliate[…]
Friday AltheaDx, Inc (Nasdaq: IDGX) – TBD Check-Cap Ltd (Nasdaq: CHEK) – TBD Columbia Pipeline Partners LP (NYSE: CPPL) – Columbia Pipeline Partners priced $2.00 above the range and upsized its offering. ‘CPPL’ priced 46.81 million shares at $23.00 and will debut on Friday. Easterly Government Properties (NYSE: DEA) – The deal has been priced[…]
Thursday Debut Advanced Accelerator Applications S.A. (Nasdaq: AAAP) – The deal has been postponed due to management’s decision not to proceed with valuation AltheaDx, Inc (Nasdaq: IDGX)– The underwriter states that this deal will now price Thursday night (2/5) in anticipation of a Friday (2/6) debut. Asante Solutions, Inc. (Nasdaq: PUMP) – The underwriter states[…]
It was a lighter month in terms of quantity of IPOs that came to market in January. Just 13 deals came to market this month as compared to 17 deals that came to market in January 2014. But with what the new issues market lacked in number, it made up for it in quality with[…]
Week of Feb. 2nd Eyegate Pharmaceuticals (Nasdaq: EYEG) Wednesday AltheaDx, Inc (Nasdaq: IDGX) Infraredx (Nasdaq: REDX) Carbylan Therapeutics (Nasdaq: CBYL) Thursday Asante Solutions, Inc. (Nasdaq: PUMP) Inotek Pharmaceuticals Corporation (Nasdaq: ITEK) Nexvet Biopharma plc (Nasdaq: NVET) Advanced Accelerator Applications S.A. (Nasdaq: AAAP) Friday Check-Cap Ltd (Nasdaq: CHEK) Columbia Pipeline Partners LP (NYSE: CPPL) Easterly Government[…]
This past week ten IPOs debuted, six updated terms and zero new deals filed. Of the ten deals that came to market, two of them—Shake Shack (NYSE: SHAK) and Spark Therapeutics (Nasdaq: ONCE)—closed their opening day with more than a 100% premium above their respective offering prices. It was the first time two IPOs
Friday’s IPO–Shake Shack (NYSE: SHAK)–will likely be the deal of the week. We were quoted in an Investors.Com article about why the deal is so hot. “It’s a fast-growth story,” said Jeff Zell, research analyst at IPOboutique. “Almost all of the fast-casual restaurant deals in the past year have all popped above their offering price.”[…]
Flex Pharma (Nasdaq: FLKS) – Flex Pharma upsizes and prices deal above range. Flex prices 5.4 million shares at $16.00. The initial filing stated that they would offer 4.6 million shares at a range of $12-$14. Entellus Medical (Nasdaq: ENTL) – Entellus Medical upsizes IPO and prices at top end of range. The deal was[…]
Last week, CNBC’s popular hosts gave a raving review about Box’s upcoming IPO. The deal opened 44% higher and traded as high as 77% above the IPO price. This week, Cramer is on the prowl for another IPO: Shake Shack (NYSE: SHAK)
Tuesday Zosano Pharma (Nasdaq: ZSAN) Wednesday Presbia PLC (Nasdaq: LENS) Thursday Ascendis Pharma A/S (Nasdaq: ASND) Entellus Medical (Nasdaq: ENTL) Flex Pharma (Nasdaq: FLKS) Friday Avinger (Nasdaq: AVGR) Infraredx (Nasdaq: REDX) InfraREIT (NYSE: HIFR) Shake Shack (NYSE: SHAK) Spark Therapeutics (Nasdaq: ONCE) Tracon Pharmaceuticals (Nasdaq: TCON) Subscribe now to get our full research report, IPO[…]
This past week one IPO debuted, twelve updated terms and one new deal filed. A highly anticipated deal, Box Inc. (NYSE: BOX), came to market on Friday after pricing $1 above the range ($14). ‘BOX’ opened 44% higher with a $20.20 print at first trade. Box fared even better in the aftermarket as the deal[…]
Last night, Box, Inc. (NYSE: BOX) priced its IPO $1 above the $11-$13 range at $14. The deal was 12.5 million shares and raised $175 million for the company. Box was the subject of a lot of media speculation this week. Box was valued at $2.4 billion during its last round of funding yet is[…]
According to the lead underwriter, Box, Inc. (NYSE: BOX) has priced 12.5 million shares at $14 and will debut on Friday (1/23). The initial range for the IPO as provided by the prospectus was $11-$13.
Fortune quotes a partner at venture capitalist Benchmark, Bill Gurley, in their February cover story: “I think you’re going to see a lot of failure in 2015.” The idea that tech start-ups can have a $1b valuation relatively easy is head scratching to some money-managers. The downfalls of repeated rounds of funding is laid out[…]
There is just one IPO on the schedule this week, Box, Inc. (NYSE: BOX) and it has at least one endorsement—one from CNBC’s Mad Money host Jim Cramer. “I bet a big thaw could be coming later this week in the form of a new offering that could get people very excited about IPOs again,”[…]